Daejeon, South Korea

Ho Chin Kim

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Samyang Corporation. Active years: 2004.


% Patents Active = 100.0


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 40(Granted Patents)


Company Filing History:


Years Active: 2004

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ho Chin Kim - Innovator in Transdermal Drug Delivery Systems

Introduction

Ho Chin Kim is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of drug delivery systems, particularly through his innovative designs and patents. His work focuses on enhancing the efficacy and convenience of medication administration.

Latest Patents

One of Ho Chin Kim's key patents is the "Dual Adhesive Transdermal Drug Delivery System." This invention comprises a support layer, a first drug-containing adhesive layer, and a second drug-containing adhesive layer. Each layer has a proximal and distal surface, with the distal surfaces laminated to the support layer. Additionally, a peelable backing layer is positioned over and laminated to the proximal surfaces of the adhesive layers. This innovative design aims to improve the delivery of medications through the skin.

Career Highlights

Ho Chin Kim is currently employed at Samyang Corporation, where he continues to develop and refine drug delivery technologies. His expertise in this area has positioned him as a valuable asset to the company and the broader pharmaceutical industry.

Collaborations

Ho Chin Kim has collaborated with several talented individuals in his field, including Young Kweon Choi and Hyun Suk Yu. These partnerships have fostered innovation and contributed to the advancement of drug delivery systems.

Conclusion

Ho Chin Kim's work in transdermal drug delivery systems exemplifies the importance of innovation in healthcare. His contributions are paving the way for more effective and user-friendly medication administration methods.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…